

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 8.97797304 |
| 2 | negative regulation of cell killing (GO:0031342) | 8.97797304 |
| 3 | interferon-gamma production (GO:0032609) | 8.71890851 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.31434960 |
| 5 | negative T cell selection (GO:0043383) | 7.28586609 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.16350304 |
| 7 | negative thymic T cell selection (GO:0045060) | 7.03719137 |
| 8 | positive thymic T cell selection (GO:0045059) | 6.87205173 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.14549947 |
| 10 | positive T cell selection (GO:0043368) | 6.11608770 |
| 11 | response to interleukin-15 (GO:0070672) | 6.07077472 |
| 12 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 6.04571298 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 5.90315661 |
| 14 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.87405386 |
| 15 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.87405386 |
| 16 | thymic T cell selection (GO:0045061) | 5.78130911 |
| 17 | T cell migration (GO:0072678) | 5.75546624 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 5.46518869 |
| 19 | * regulation of isotype switching to IgG isotypes (GO:0048302) | 5.41606306 |
| 20 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.36299947 |
| 21 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.36299947 |
| 22 | activated T cell proliferation (GO:0050798) | 5.32334936 |
| 23 | T cell selection (GO:0045058) | 5.11297386 |
| 24 | negative regulation of T cell mediated immunity (GO:0002710) | 4.96635603 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.92998318 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.76895185 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.76895185 |
| 28 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.70628943 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.68652002 |
| 30 | natural killer cell activation (GO:0030101) | 4.64245492 |
| 31 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.56266062 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 4.38018271 |
| 33 | daunorubicin metabolic process (GO:0044597) | 4.32373625 |
| 34 | polyketide metabolic process (GO:0030638) | 4.32373625 |
| 35 | doxorubicin metabolic process (GO:0044598) | 4.32373625 |
| 36 | T cell costimulation (GO:0031295) | 4.31609209 |
| 37 | lymphocyte costimulation (GO:0031294) | 4.23308715 |
| 38 | positive regulation of humoral immune response (GO:0002922) | 4.22411096 |
| 39 | regulation of cell killing (GO:0031341) | 4.21179568 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.15980048 |
| 41 | leukocyte aggregation (GO:0070486) | 4.12540936 |
| 42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.11984705 |
| 43 | positive regulation of cell killing (GO:0031343) | 4.11333622 |
| 44 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.10943427 |
| 45 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.10438717 |
| 46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.08019862 |
| 47 | T cell receptor signaling pathway (GO:0050852) | 4.04678227 |
| 48 | * positive regulation of isotype switching (GO:0045830) | 4.00423274 |
| 49 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.98469704 |
| 50 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.88038469 |
| 51 | positive regulation by symbiont of host defense response (GO:0052509) | 3.85129862 |
| 52 | modulation by symbiont of host defense response (GO:0052031) | 3.85129862 |
| 53 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.85129862 |
| 54 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.85129862 |
| 55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.85129862 |
| 56 | modulation by symbiont of host immune response (GO:0052553) | 3.85129862 |
| 57 | * positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.82179833 |
| 58 | * positive regulation of B cell mediated immunity (GO:0002714) | 3.82179833 |
| 59 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.80329186 |
| 60 | microglial cell activation (GO:0001774) | 3.80153610 |
| 61 | T cell differentiation involved in immune response (GO:0002292) | 3.76843692 |
| 62 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.76843692 |
| 63 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.76843692 |
| 64 | mast cell activation (GO:0045576) | 3.72072765 |
| 65 | type I interferon signaling pathway (GO:0060337) | 3.71044184 |
| 66 | cellular response to type I interferon (GO:0071357) | 3.71044184 |
| 67 | response to type I interferon (GO:0034340) | 3.70506519 |
| 68 | detection of bacterium (GO:0016045) | 3.70484305 |
| 69 | detection of other organism (GO:0098543) | 3.64227877 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 3.63173066 |
| 71 | mast cell activation involved in immune response (GO:0002279) | 3.49196770 |
| 72 | mast cell degranulation (GO:0043303) | 3.49196770 |
| 73 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.49191267 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 3.47744174 |
| 75 | T cell proliferation (GO:0042098) | 3.43143902 |
| 76 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.42477007 |
| 77 | alpha-beta T cell activation (GO:0046631) | 3.42368773 |
| 78 | maintenance of protein location in nucleus (GO:0051457) | 3.41824582 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.40454547 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.40454547 |
| 81 | * positive regulation of DNA recombination (GO:0045911) | 3.39969211 |
| 82 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.38787900 |
| 83 | B cell receptor signaling pathway (GO:0050853) | 3.38189260 |
| 84 | * regulation of immunoglobulin mediated immune response (GO:0002889) | 3.37713005 |
| 85 | regulation of T cell tolerance induction (GO:0002664) | 3.36173564 |
| 86 | regulation of B cell differentiation (GO:0045577) | 3.35936432 |
| 87 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.34228135 |
| 88 | tolerance induction (GO:0002507) | 3.32925867 |
| 89 | regulation of response to interferon-gamma (GO:0060330) | 3.32889140 |
| 90 | positive regulation of T cell mediated immunity (GO:0002711) | 3.31012974 |
| 91 | heterotypic cell-cell adhesion (GO:0034113) | 3.30527524 |
| 92 | regulation of tolerance induction (GO:0002643) | 3.30051983 |
| 93 | T-helper 1 type immune response (GO:0042088) | 3.29245648 |
| 94 | leukocyte degranulation (GO:0043299) | 3.28237824 |
| 95 | positive regulation of interleukin-2 production (GO:0032743) | 3.27893874 |
| 96 | leukocyte cell-cell adhesion (GO:0007159) | 3.27582461 |
| 97 | positive regulation of immune response to tumor cell (GO:0002839) | 3.27216386 |
| 98 | regulation of immune response to tumor cell (GO:0002837) | 3.27216386 |
| 99 | regulation of response to tumor cell (GO:0002834) | 3.27216386 |
| 100 | positive regulation of response to tumor cell (GO:0002836) | 3.27216386 |
| 101 | cytidine deamination (GO:0009972) | 3.26535318 |
| 102 | cytidine metabolic process (GO:0046087) | 3.26535318 |
| 103 | cytidine catabolic process (GO:0006216) | 3.26535318 |
| 104 | * regulation of B cell mediated immunity (GO:0002712) | 3.25000439 |
| 105 | T cell activation involved in immune response (GO:0002286) | 3.23900263 |
| 106 | defense response to protozoan (GO:0042832) | 3.22645447 |
| 107 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.22235508 |
| 108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20914053 |
| 109 | regulation of T cell mediated immunity (GO:0002709) | 3.20633883 |
| 110 | regulation of regulatory T cell differentiation (GO:0045589) | 3.20400841 |
| 111 | negative regulation of interleukin-2 production (GO:0032703) | 3.18665125 |
| 112 | NIK/NF-kappaB signaling (GO:0038061) | 3.17655278 |
| 113 | negative regulation of interleukin-12 production (GO:0032695) | 3.15264514 |
| 114 | alpha-beta T cell differentiation (GO:0046632) | 3.15031333 |
| 115 | T cell homeostasis (GO:0043029) | 3.13362669 |
| 116 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.13218915 |
| 117 | negative regulation of protein oligomerization (GO:0032460) | 3.10590154 |
| 118 | cellular defense response (GO:0006968) | 3.10498318 |
| 119 | lymphocyte homeostasis (GO:0002260) | 3.09520844 |
| 120 | negative regulation of phagocytosis (GO:0050765) | 3.09006533 |
| 121 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.08668232 |
| 122 | * lymphocyte migration (GO:0072676) | 3.08623738 |
| 123 | * regulation of isotype switching (GO:0045191) | 3.08187513 |
| 124 | positive regulation of interleukin-17 production (GO:0032740) | 3.07769692 |
| 125 | * regulation of lymphocyte mediated immunity (GO:0002706) | 3.06891646 |
| 126 | negative regulation of innate immune response (GO:0045824) | 3.04177344 |
| 127 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.04114797 |
| 128 | neutrophil activation involved in immune response (GO:0002283) | 3.03444821 |
| 129 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.02854163 |
| 130 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.01687262 |
| 131 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00717589 |
| 132 | lymph node development (GO:0048535) | 2.99644562 |
| 133 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.99498731 |
| 134 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.99301524 |
| 135 | T-helper cell differentiation (GO:0042093) | 2.99301524 |
| 136 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.98494145 |
| 137 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.97463618 |
| 138 | * positive regulation of leukocyte mediated immunity (GO:0002705) | 2.96887693 |
| 139 | positive regulation of tolerance induction (GO:0002645) | 2.94769860 |
| 140 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.94733810 |
| 141 | positive regulation of protein deacetylation (GO:0090312) | 2.94367224 |
| 142 | response to protozoan (GO:0001562) | 2.94333749 |
| 143 | positive regulation of mast cell activation (GO:0033005) | 2.93918893 |
| 144 | positive regulation of histone deacetylation (GO:0031065) | 2.92408562 |
| 145 | * T cell differentiation (GO:0030217) | 2.92036619 |
| 146 | somite rostral/caudal axis specification (GO:0032525) | 2.91416309 |
| 147 | * T cell activation (GO:0042110) | 2.90950506 |
| 148 | natural killer cell differentiation (GO:0001779) | 2.90488638 |
| 149 | regulation of interleukin-2 production (GO:0032663) | 2.89754685 |
| 150 | regulation of chronic inflammatory response (GO:0002676) | 2.87761824 |
| 151 | muscle organ morphogenesis (GO:0048644) | 2.87659452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.19682916 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.09615577 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.87169730 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.68684806 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.49569206 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.19623453 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.10535927 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.02728929 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.02407659 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.98563328 |
| 11 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.97711644 |
| 12 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.97711644 |
| 13 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.97711644 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.89554034 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.84096078 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.70061138 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.54950576 |
| 18 | * MYB_26560356_Chip-Seq_TH1_Human | 2.52220985 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50478921 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.46627476 |
| 21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.46018120 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29803660 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.28302509 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.22221666 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12597591 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.12577090 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.07280340 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.02846468 |
| 29 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.99895948 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95434899 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.91035379 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90105978 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84143130 |
| 34 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79950096 |
| 35 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.78569862 |
| 36 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78373596 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.76960978 |
| 38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74830319 |
| 39 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74813065 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.69381161 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.68332661 |
| 42 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64496323 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.63184974 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61392134 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57335001 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52458112 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51382206 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.51016194 |
| 49 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42833586 |
| 50 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.42698487 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41665496 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40768973 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40406175 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37688728 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36015235 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35725046 |
| 57 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.35145627 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35041710 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31793429 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31436277 |
| 61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30824728 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30760210 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29576352 |
| 64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.28383759 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27606112 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25372033 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23369384 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22888566 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21949633 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21679464 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21107032 |
| 72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17916621 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15212115 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14570393 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13009054 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12729077 |
| 77 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11361159 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09230557 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06496597 |
| 80 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05289324 |
| 81 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04529258 |
| 82 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04230036 |
| 83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03622678 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02676219 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01647468 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00371024 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96135933 |
| 88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95533859 |
| 89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95471218 |
| 90 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94812384 |
| 91 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94246171 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94170270 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93286361 |
| 94 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92893546 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92432973 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92352178 |
| 97 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92351606 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90991480 |
| 99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90500050 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90428188 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90260614 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90242017 |
| 103 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89281717 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89108946 |
| 105 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88713767 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88706738 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88586813 |
| 108 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88379259 |
| 109 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88368281 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88175324 |
| 111 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.87745539 |
| 112 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86895375 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.86031306 |
| 114 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.84570704 |
| 115 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84569538 |
| 116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83447598 |
| 117 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.82065052 |
| 118 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81741119 |
| 119 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81654775 |
| 120 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81016171 |
| 121 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80718951 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80328905 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80198978 |
| 124 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.80038937 |
| 125 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79147002 |
| 126 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78054250 |
| 127 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77328229 |
| 128 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.77259499 |
| 129 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.77230825 |
| 130 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77211468 |
| 131 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.76979226 |
| 132 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76674035 |
| 133 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.75250374 |
| 134 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.72425334 |
| 135 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.72014846 |
| 136 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.71765769 |
| 137 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70886570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.04739811 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.64245585 |
| 3 | MP0000685_abnormal_immune_system | 3.51943266 |
| 4 | * MP0006082_CNS_inflammation | 3.16426258 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.11583185 |
| 6 | * MP0001800_abnormal_humoral_immune | 3.09808719 |
| 7 | MP0009785_altered_susceptibility_to | 2.80194697 |
| 8 | MP0001790_abnormal_immune_system | 2.77917644 |
| 9 | MP0005387_immune_system_phenotype | 2.77917644 |
| 10 | * MP0002420_abnormal_adaptive_immunity | 2.63048613 |
| 11 | * MP0001819_abnormal_immune_cell | 2.59196914 |
| 12 | * MP0005000_abnormal_immune_tolerance | 2.58814164 |
| 13 | * MP0002723_abnormal_immune_serum | 2.57911833 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.54614366 |
| 15 | * MP0002405_respiratory_system_inflammati | 2.52700986 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.50601079 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.46615801 |
| 18 | MP0000703_abnormal_thymus_morphology | 2.32293175 |
| 19 | * MP0005025_abnormal_response_to | 2.31950304 |
| 20 | MP0002254_reproductive_system_inflammat | 2.29281806 |
| 21 | * MP0002452_abnormal_antigen_presenting | 2.25949880 |
| 22 | * MP0000716_abnormal_immune_system | 2.25487328 |
| 23 | MP0003436_decreased_susceptibility_to | 2.22212560 |
| 24 | MP0002722_abnormal_immune_system | 2.20660616 |
| 25 | MP0003448_altered_tumor_morphology | 2.09622239 |
| 26 | MP0003690_abnormal_glial_cell | 2.08017741 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.05428668 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 2.02715531 |
| 29 | MP0003300_gastrointestinal_ulcer | 2.00854499 |
| 30 | MP0008057_abnormal_DNA_replication | 1.96535809 |
| 31 | MP0004264_abnormal_extraembryonic_tissu | 1.94131219 |
| 32 | MP0004947_skin_inflammation | 1.89420207 |
| 33 | * MP0002429_abnormal_blood_cell | 1.88654986 |
| 34 | MP0001873_stomach_inflammation | 1.88392519 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.85274672 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.74601224 |
| 37 | MP0002006_tumorigenesis | 1.71316192 |
| 38 | * MP0010155_abnormal_intestine_physiology | 1.68384169 |
| 39 | MP0004957_abnormal_blastocyst_morpholog | 1.67265398 |
| 40 | * MP0000858_altered_metastatic_potential | 1.62455445 |
| 41 | MP0003866_abnormal_defecation | 1.59246015 |
| 42 | MP0004883_abnormal_blood_vessel | 1.56846074 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.52336213 |
| 44 | MP0003011_delayed_dark_adaptation | 1.49343242 |
| 45 | MP0003045_fibrosis | 1.48332988 |
| 46 | * MP0001845_abnormal_inflammatory_respons | 1.42982042 |
| 47 | MP0005310_abnormal_salivary_gland | 1.42179222 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.38062143 |
| 49 | MP0003890_abnormal_embryonic-extraembry | 1.36757221 |
| 50 | MP0000490_abnormal_crypts_of | 1.33282803 |
| 51 | MP0002419_abnormal_innate_immunity | 1.32840819 |
| 52 | MP0002933_joint_inflammation | 1.32088778 |
| 53 | MP0001663_abnormal_digestive_system | 1.29434232 |
| 54 | MP0004381_abnormal_hair_follicle | 1.27393468 |
| 55 | * MP0002019_abnormal_tumor_incidence | 1.22563292 |
| 56 | MP0003828_pulmonary_edema | 1.20858934 |
| 57 | MP0003724_increased_susceptibility_to | 1.20170037 |
| 58 | MP0001853_heart_inflammation | 1.17959678 |
| 59 | MP0001851_eye_inflammation | 1.17747260 |
| 60 | MP0005499_abnormal_olfactory_system | 1.16876346 |
| 61 | MP0005394_taste/olfaction_phenotype | 1.16876346 |
| 62 | MP0003077_abnormal_cell_cycle | 1.06689281 |
| 63 | MP0004510_myositis | 1.04459854 |
| 64 | MP0009764_decreased_sensitivity_to | 0.99045894 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 0.98626316 |
| 66 | MP0001348_abnormal_lacrimal_gland | 0.96874554 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.96581928 |
| 68 | MP0006292_abnormal_olfactory_placode | 0.94196189 |
| 69 | MP0005164_abnormal_response_to | 0.93775000 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.91870691 |
| 71 | MP0005023_abnormal_wound_healing | 0.87443278 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.86858061 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 0.86746845 |
| 74 | MP0000350_abnormal_cell_proliferation | 0.85938630 |
| 75 | MP0000920_abnormal_myelination | 0.85255220 |
| 76 | MP0004858_abnormal_nervous_system | 0.85162006 |
| 77 | MP0005408_hypopigmentation | 0.84119214 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.83800272 |
| 79 | * MP0008469_abnormal_protein_level | 0.82658569 |
| 80 | MP0002086_abnormal_extraembryonic_tissu | 0.80486879 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.78766601 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.77712095 |
| 83 | MP0005381_digestive/alimentary_phenotyp | 0.77401701 |
| 84 | MP0005380_embryogenesis_phenotype | 0.77271936 |
| 85 | MP0001672_abnormal_embryogenesis/_devel | 0.77271936 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.76683011 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.76497043 |
| 88 | MP0002088_abnormal_embryonic_growth/wei | 0.75712405 |
| 89 | MP0008007_abnormal_cellular_replicative | 0.74756452 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.72763782 |
| 91 | MP0003984_embryonic_growth_retardation | 0.72327628 |
| 92 | MP0002127_abnormal_cardiovascular_syste | 0.72167388 |
| 93 | MP0003705_abnormal_hypodermis_morpholog | 0.71367840 |
| 94 | MP0000249_abnormal_blood_vessel | 0.69649412 |
| 95 | MP0009763_increased_sensitivity_to | 0.68259788 |
| 96 | MP0003121_genomic_imprinting | 0.67907823 |
| 97 | MP0000609_abnormal_liver_physiology | 0.67904810 |
| 98 | MP0005647_abnormal_sex_gland | 0.67877156 |
| 99 | MP0000313_abnormal_cell_death | 0.67522371 |
| 100 | MP0009278_abnormal_bone_marrow | 0.66943101 |
| 101 | MP0003693_abnormal_embryo_hatching | 0.66921701 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.65904896 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 0.65722865 |
| 104 | MP0010094_abnormal_chromosome_stability | 0.65185050 |
| 105 | MP0000613_abnormal_salivary_gland | 0.65113285 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.62780345 |
| 107 | * MP0002132_abnormal_respiratory_system | 0.61299129 |
| 108 | MP0008770_decreased_survivor_rate | 0.61189048 |
| 109 | MP0010307_abnormal_tumor_latency | 0.60333704 |
| 110 | MP0008874_decreased_physiological_sensi | 0.60149922 |
| 111 | MP0005451_abnormal_body_composition | 0.59355922 |
| 112 | MP0001243_abnormal_dermal_layer | 0.58752694 |
| 113 | MP0005166_decreased_susceptibility_to | 0.58481160 |
| 114 | MP0001915_intracranial_hemorrhage | 0.57856377 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 0.57252144 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.57252144 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.56695189 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.55384336 |
| 119 | MP0000477_abnormal_intestine_morphology | 0.53762082 |
| 120 | MP0005390_skeleton_phenotype | 0.53614301 |
| 121 | MP0002970_abnormal_white_adipose | 0.53430443 |
| 122 | MP0003303_peritoneal_inflammation | 0.52799200 |
| 123 | MP0003111_abnormal_nucleus_morphology | 0.52275247 |
| 124 | MP0003191_abnormal_cellular_cholesterol | 0.51465392 |
| 125 | MP0008873_increased_physiological_sensi | 0.51305060 |
| 126 | MP0003075_altered_response_to | 0.50065952 |
| 127 | MP0003252_abnormal_bile_duct | 0.49870153 |
| 128 | MP0000470_abnormal_stomach_morphology | 0.48997956 |
| 129 | MP0002163_abnormal_gland_morphology | 0.44864608 |
| 130 | MP0003795_abnormal_bone_structure | 0.43888967 |
| 131 | MP0008260_abnormal_autophagy | 0.43856053 |
| 132 | MP0000569_abnormal_digit_pigmentation | 0.43061596 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.42233895 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.41834197 |
| 135 | MP0000604_amyloidosis | 0.41745389 |
| 136 | MP0001346_abnormal_lacrimal_gland | 0.40707430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.00397527 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.65531150 |
| 3 | Combined immunodeficiency (HP:0005387) | 5.39456263 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.89630518 |
| 5 | Myositis (HP:0100614) | 4.74564821 |
| 6 | Abnormality of T cells (HP:0002843) | 4.72723739 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.70945842 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.56482646 |
| 9 | Orchitis (HP:0100796) | 4.20718697 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 4.10444545 |
| 11 | Bilateral microphthalmos (HP:0007633) | 4.09045473 |
| 12 | Recurrent bronchitis (HP:0002837) | 3.88906310 |
| 13 | Multiple enchondromatosis (HP:0005701) | 3.78734607 |
| 14 | Recurrent skin infections (HP:0001581) | 3.75142510 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 3.62066441 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 3.52979144 |
| 17 | Optic neuritis (HP:0100653) | 3.51337864 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.51337864 |
| 19 | Encephalitis (HP:0002383) | 3.47481137 |
| 20 | Increased IgM level (HP:0003496) | 3.41355190 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.39908735 |
| 22 | Stomatitis (HP:0010280) | 3.37983203 |
| 23 | Hypochromic microcytic anemia (HP:0004840) | 3.34830554 |
| 24 | Obstructive lung disease (HP:0006536) | 3.34498922 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.34498922 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.33738243 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21301532 |
| 28 | Rib fusion (HP:0000902) | 3.19099350 |
| 29 | IgM deficiency (HP:0002850) | 3.17223249 |
| 30 | Recurrent viral infections (HP:0004429) | 3.16437368 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.15676583 |
| 32 | Hemiplegia (HP:0002301) | 3.14839246 |
| 33 | * Nasal polyposis (HP:0100582) | 3.08332541 |
| 34 | Joint swelling (HP:0001386) | 3.04970942 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 2.95125342 |
| 36 | Chronic otitis media (HP:0000389) | 2.93979751 |
| 37 | Pulmonary infiltrates (HP:0002113) | 2.91228215 |
| 38 | Urticaria (HP:0001025) | 2.87252596 |
| 39 | Stomach cancer (HP:0012126) | 2.85193718 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.83951469 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.83951469 |
| 42 | IgG deficiency (HP:0004315) | 2.81674059 |
| 43 | Hepatoblastoma (HP:0002884) | 2.71657060 |
| 44 | Zonular cataract (HP:0010920) | 2.70306283 |
| 45 | Abnormality of B cell number (HP:0010975) | 2.69390557 |
| 46 | Hypoproteinemia (HP:0003075) | 2.68752902 |
| 47 | Eczematoid dermatitis (HP:0000976) | 2.68570114 |
| 48 | Leukocytosis (HP:0001974) | 2.66131149 |
| 49 | Abnormality of eosinophils (HP:0001879) | 2.64453877 |
| 50 | Meningitis (HP:0001287) | 2.64365861 |
| 51 | Thrombocytosis (HP:0001894) | 2.62976668 |
| 52 | Amyotrophic lateral sclerosis (HP:0007354) | 2.62575695 |
| 53 | Gingivitis (HP:0000230) | 2.54868180 |
| 54 | Vasculitis (HP:0002633) | 2.54120578 |
| 55 | Abnormality of the lower motor neuron (HP:0002366) | 2.53306433 |
| 56 | Pustule (HP:0200039) | 2.52947673 |
| 57 | Cheilitis (HP:0100825) | 2.49924706 |
| 58 | Tetraplegia (HP:0002445) | 2.49175659 |
| 59 | Hypochromic anemia (HP:0001931) | 2.48749497 |
| 60 | Keratitis (HP:0000491) | 2.46882078 |
| 61 | Hemoptysis (HP:0002105) | 2.44448853 |
| 62 | Chest pain (HP:0100749) | 2.44319734 |
| 63 | Prolonged bleeding time (HP:0003010) | 2.40674687 |
| 64 | Ependymoma (HP:0002888) | 2.37146442 |
| 65 | * Abnormality of the nasal mucosa (HP:0000433) | 2.37131889 |
| 66 | Gastrointestinal stroma tumor (HP:0100723) | 2.36995382 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.34639341 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.32317998 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.31519714 |
| 70 | Thyroiditis (HP:0100646) | 2.30589528 |
| 71 | Lymphoma (HP:0002665) | 2.28112584 |
| 72 | Gingival bleeding (HP:0000225) | 2.27790133 |
| 73 | Bronchitis (HP:0012387) | 2.24112716 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.21823932 |
| 75 | Anomalous pulmonary venous return (HP:0010772) | 2.21383090 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.19749039 |
| 77 | Gangrene (HP:0100758) | 2.17822423 |
| 78 | Eosinophilia (HP:0001880) | 2.15625710 |
| 79 | Cellulitis (HP:0100658) | 2.15353777 |
| 80 | Chronic diarrhea (HP:0002028) | 2.14534783 |
| 81 | Epistaxis (HP:0000421) | 2.14329412 |
| 82 | Arterial thrombosis (HP:0004420) | 2.10360119 |
| 83 | Dislocated radial head (HP:0003083) | 2.09760306 |
| 84 | Intestinal fistula (HP:0100819) | 2.09495186 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 2.09440060 |
| 86 | Neoplasm of striated muscle (HP:0009728) | 2.09270527 |
| 87 | Gastrointestinal infarctions (HP:0005244) | 2.07896972 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 2.05713076 |
| 89 | Abnormality of the fingertips (HP:0001211) | 2.05284679 |
| 90 | Recurrent sinusitis (HP:0011108) | 2.04745577 |
| 91 | Increased IgE level (HP:0003212) | 2.04631007 |
| 92 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.04380619 |
| 93 | Lymphopenia (HP:0001888) | 2.03700269 |
| 94 | Rhabdomyosarcoma (HP:0002859) | 2.03338810 |
| 95 | Oral leukoplakia (HP:0002745) | 2.02560288 |
| 96 | Increased CSF protein (HP:0002922) | 2.02503320 |
| 97 | Preauricular skin tag (HP:0000384) | 2.01511429 |
| 98 | Abnormality of the prostate (HP:0008775) | 1.99924461 |
| 99 | Hypoalbuminemia (HP:0003073) | 1.99687224 |
| 100 | Abnormal albumin level (HP:0012116) | 1.99687224 |
| 101 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99686117 |
| 102 | Leukopenia (HP:0001882) | 1.99191742 |
| 103 | Skin tags (HP:0010609) | 1.97825757 |
| 104 | Sepsis (HP:0100806) | 1.96644020 |
| 105 | Episodic fever (HP:0001954) | 1.96615635 |
| 106 | Skin ulcer (HP:0200042) | 1.95700572 |
| 107 | Emphysema (HP:0002097) | 1.95207877 |
| 108 | Anorexia (HP:0002039) | 1.95088682 |
| 109 | Flat occiput (HP:0005469) | 1.94778939 |
| 110 | Abnormality of the radial head (HP:0003995) | 1.93648597 |
| 111 | Polyneuropathy (HP:0001271) | 1.93264834 |
| 112 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.92207816 |
| 113 | Villous atrophy (HP:0011473) | 1.92207816 |
| 114 | Abnormality of oral frenula (HP:0000190) | 1.92088447 |
| 115 | Verrucae (HP:0200043) | 1.91786857 |
| 116 | Papilloma (HP:0012740) | 1.91786857 |
| 117 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.89990514 |
| 118 | IgA deficiency (HP:0002720) | 1.89852474 |
| 119 | Spontaneous hematomas (HP:0007420) | 1.89147145 |
| 120 | Glomerulopathy (HP:0100820) | 1.88629267 |
| 121 | Amaurosis fugax (HP:0100576) | 1.88310179 |
| 122 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.86933677 |
| 123 | Large earlobe (HP:0009748) | 1.86902414 |
| 124 | Autoimmune hemolytic anemia (HP:0001890) | 1.86067062 |
| 125 | Agammaglobulinemia (HP:0004432) | 1.84990647 |
| 126 | Increased serum ferritin (HP:0003281) | 1.84794969 |
| 127 | Rectovaginal fistula (HP:0000143) | 1.83636488 |
| 128 | Rectal fistula (HP:0100590) | 1.83636488 |
| 129 | Abnormality of the pulmonary veins (HP:0011718) | 1.82987664 |
| 130 | Hypergammaglobulinemia (HP:0010702) | 1.80895766 |
| 131 | Prominent nose (HP:0000448) | 1.80644744 |
| 132 | Ragged-red muscle fibers (HP:0003200) | 1.80614748 |
| 133 | Reduced antithrombin III activity (HP:0001976) | 1.78589625 |
| 134 | Granulocytopenia (HP:0001913) | 1.77090736 |
| 135 | Pulmonary embolism (HP:0002204) | 1.76870096 |
| 136 | Recurrent abscess formation (HP:0002722) | 1.76054889 |
| 137 | Mediastinal lymphadenopathy (HP:0100721) | 1.74167937 |
| 138 | Colitis (HP:0002583) | 1.72829510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 4.94985313 |
| 2 | MAP4K1 | 4.44442631 |
| 3 | TXK | 4.43016855 |
| 4 | GRK6 | 4.23582312 |
| 5 | RIPK4 | 3.55307439 |
| 6 | STK10 | 3.36348375 |
| 7 | JAK3 | 2.59937944 |
| 8 | ERN1 | 2.52964544 |
| 9 | GRK5 | 2.51943373 |
| 10 | PASK | 2.50573870 |
| 11 | CSK | 2.50090250 |
| 12 | ADRBK2 | 2.37533856 |
| 13 | PRPF4B | 2.25002161 |
| 14 | ZAP70 | 2.23836297 |
| 15 | JAK1 | 2.13771740 |
| 16 | TYRO3 | 2.11548460 |
| 17 | TAOK3 | 2.09524037 |
| 18 | FGFR3 | 2.08832677 |
| 19 | GRK7 | 2.05035788 |
| 20 | * ITK | 1.99186497 |
| 21 | TGFBR2 | 1.93438352 |
| 22 | MAP3K10 | 1.89883747 |
| 23 | CSF1R | 1.89694932 |
| 24 | TYK2 | 1.81407326 |
| 25 | FGFR4 | 1.80414504 |
| 26 | PTK2B | 1.76603215 |
| 27 | FGR | 1.71758928 |
| 28 | MAP2K3 | 1.53163745 |
| 29 | LCK | 1.51735749 |
| 30 | MAPK7 | 1.48841663 |
| 31 | GRK1 | 1.42285173 |
| 32 | MST4 | 1.39341374 |
| 33 | MAP3K14 | 1.38978059 |
| 34 | MAP2K6 | 1.33727844 |
| 35 | MAP3K11 | 1.32548035 |
| 36 | IKBKE | 1.31512143 |
| 37 | IKBKB | 1.25750233 |
| 38 | BLK | 1.23933735 |
| 39 | CAMKK1 | 1.23038619 |
| 40 | MAP3K7 | 1.17309665 |
| 41 | PRKCH | 1.10765371 |
| 42 | ALK | 1.09432278 |
| 43 | MAP3K3 | 1.08473059 |
| 44 | PRKCQ | 1.06635376 |
| 45 | MAP3K12 | 1.05863417 |
| 46 | MARK2 | 1.05285195 |
| 47 | HCK | 1.03312134 |
| 48 | HIPK2 | 0.95981148 |
| 49 | SYK | 0.94830183 |
| 50 | NLK | 0.93704446 |
| 51 | TEC | 0.91946451 |
| 52 | MELK | 0.90046637 |
| 53 | BTK | 0.89273870 |
| 54 | TBK1 | 0.87690809 |
| 55 | CDK4 | 0.85092066 |
| 56 | TRIB3 | 0.85030554 |
| 57 | WNK1 | 0.84549973 |
| 58 | PRKG2 | 0.84080860 |
| 59 | TAOK2 | 0.83021223 |
| 60 | TESK2 | 0.82621693 |
| 61 | SIK2 | 0.80953719 |
| 62 | KDR | 0.78286753 |
| 63 | PIM1 | 0.78092193 |
| 64 | TAOK1 | 0.75800614 |
| 65 | MOS | 0.75368018 |
| 66 | EEF2K | 0.74743551 |
| 67 | BMPR2 | 0.72676414 |
| 68 | CHUK | 0.72569521 |
| 69 | EPHA3 | 0.70039904 |
| 70 | EPHB1 | 0.69866457 |
| 71 | JAK2 | 0.67295936 |
| 72 | LRRK2 | 0.64776991 |
| 73 | MARK3 | 0.64493838 |
| 74 | RPS6KA4 | 0.62360430 |
| 75 | TNK2 | 0.59467996 |
| 76 | CAMK4 | 0.58107487 |
| 77 | DMPK | 0.56409806 |
| 78 | CDK7 | 0.55887512 |
| 79 | MAP3K1 | 0.54139970 |
| 80 | MATK | 0.53617514 |
| 81 | CLK1 | 0.53116997 |
| 82 | FES | 0.51996120 |
| 83 | CDK9 | 0.50792988 |
| 84 | MAP3K5 | 0.50094287 |
| 85 | INSR | 0.49999395 |
| 86 | KIT | 0.49874647 |
| 87 | PAK4 | 0.49585698 |
| 88 | IGF1R | 0.49560892 |
| 89 | PRKD2 | 0.48286190 |
| 90 | MAP3K13 | 0.47846667 |
| 91 | PTK6 | 0.47677288 |
| 92 | PDPK1 | 0.47292435 |
| 93 | LYN | 0.44696910 |
| 94 | NEK2 | 0.43203114 |
| 95 | TSSK6 | 0.42947313 |
| 96 | MAPK12 | 0.42335615 |
| 97 | CHEK1 | 0.38681380 |
| 98 | TTK | 0.38285458 |
| 99 | SMG1 | 0.38056917 |
| 100 | PRKCZ | 0.37049828 |
| 101 | STK38 | 0.36877828 |
| 102 | PDK1 | 0.35736455 |
| 103 | YES1 | 0.34593626 |
| 104 | TTN | 0.34058309 |
| 105 | ADRBK1 | 0.33971292 |
| 106 | PDGFRB | 0.30569556 |
| 107 | BRD4 | 0.28793535 |
| 108 | PKN1 | 0.28371132 |
| 109 | IRAK4 | 0.27592943 |
| 110 | PIK3CG | 0.27506264 |
| 111 | CDC42BPA | 0.26871871 |
| 112 | MAP3K8 | 0.26621132 |
| 113 | NME2 | 0.25926539 |
| 114 | SIK3 | 0.25103468 |
| 115 | PRKCD | 0.23884773 |
| 116 | MTOR | 0.23587631 |
| 117 | PRKAA2 | 0.22524805 |
| 118 | SIK1 | 0.21783409 |
| 119 | FGFR1 | 0.19825558 |
| 120 | MAPK3 | 0.19760743 |
| 121 | IRAK1 | 0.19664744 |
| 122 | RIPK1 | 0.19222654 |
| 123 | MAPK11 | 0.19204884 |
| 124 | FYN | 0.18625108 |
| 125 | KSR2 | 0.18367820 |
| 126 | CAMKK2 | 0.17539111 |
| 127 | ABL1 | 0.17519489 |
| 128 | CDK2 | 0.17113428 |
| 129 | MAPKAPK2 | 0.16294080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.97211049 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.72646701 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.83883768 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.53795815 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.17894471 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.96872832 |
| 7 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.79023542 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.34698102 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30303897 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.23311649 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.18489609 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05456244 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.86175203 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79733830 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.77915317 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69577129 |
| 17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.54492835 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.50506621 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50453213 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47906592 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46594613 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46522307 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45442901 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43645612 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31493727 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26530584 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.25243555 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25143477 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24134572 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.24090636 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.22065646 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19008853 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18863120 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16575294 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16463798 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14664300 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12080916 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.09601226 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 1.06254311 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00861104 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 0.95237546 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90823983 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 0.90544868 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84411356 |
| 45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83931281 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.80017889 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79652764 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77464663 |
| 49 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73317981 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 0.72394514 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68570418 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68567276 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67065373 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66248206 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.66023339 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63160405 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63137387 |
| 58 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62218042 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.62052093 |
| 60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61611483 |
| 61 | Ribosome_Homo sapiens_hsa03010 | 0.59433654 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58504759 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56606540 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.55795053 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55173344 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54291612 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53175512 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.52009292 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51810901 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.50699150 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50515017 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50492422 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50339447 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49913347 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47920364 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45934584 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44838851 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.44509521 |
| 79 | RNA transport_Homo sapiens_hsa03013 | 0.44363849 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43866394 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43523019 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43297464 |
| 83 | Spliceosome_Homo sapiens_hsa03040 | 0.43267360 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41211198 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40478928 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38762686 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38697873 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38080789 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37532826 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37338277 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.37172989 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36946590 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36333178 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34657471 |
| 95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32716828 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.32205294 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.32181674 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31897224 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.31408783 |
| 100 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31359168 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30003781 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29917835 |
| 103 | DNA replication_Homo sapiens_hsa03030 | 0.28723451 |
| 104 | Cell cycle_Homo sapiens_hsa04110 | 0.27504567 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26583796 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26180359 |
| 107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.25383654 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23494985 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23363506 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23311137 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22657258 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.21775352 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.21543139 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20822051 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20655354 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.19650749 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18225425 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.17274730 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16736224 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.14051515 |
| 121 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.11668400 |
| 122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.10841546 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.08875393 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08655644 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.07407780 |

